Caregen Investor Relations

Caregen Co., Ltd., a biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide. The company offers filler products under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG Styler 600 names; skin care products under the Dermaheal, PURILUX whitening, Pim-Pim-Paul, and Neovert names; scalp care products under the Renokin and Pelo Baum names; and healthy foods under the proGsterol name. It is also developing medicines for COVID-19 treatment, wet macular degeneration, dry macular degeneration, antiviral drugs, diabetic retinopathy, cataract, hyperhidrosis, pain relief, hair loss, obesity, psoriasis, wound, arthritis, and rhinitis; medical equipment for facial beauty, scalp/hair improvement, body care, and arthritis; cosmetics for wrinkle improvement, whitening, scalp/hair improvement, acne care, UV protection, atopy improvement, fine dust blocking, dark circles, cellulite reduction, and sebum secretion control; and food for blood sugar control, improved liver function, hangover cure, cholesterol control, and body fat reduction. Caregen Co., Ltd. was founded in 2001 and is based in Anyang-Si, South Korea.

Read Less